Skip to content

Effects of epigallocatechin gallate (EGCG) and Cissus Quadrangularis extract on adiposity, metabolic profiles, serum leptin, and resting metabolic rate

Effects of epigallocatechin gallate (EGCG) and Cissus Quadrangularis extract on adiposity, metabolic profiles, serum leptin, and resting metabolic rate

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20200422001
Enrollment
Unknown
Registered
2020-04-21
Start date
2015-10-19
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity and obesity related parameters obesity&#44

Interventions

A starch capsule was given to subjects twice a day after breakfast and dinner for 8 weeks with no dietary restriction.,A capsule of 300 mg Cissus Quadrangularis(CQ)extract was given to subjects twice
Placebo,Cissus Quadrangularis (CQ) extract,Epigallocatechin gallate (EGCG)

Sponsors

Faculty of Medicine Siriraj Hospital, Mahidol University
Lead Sponsor
The Thailand Research Fund (TRF) through the Royal Golden Jubilee Ph.D. Program
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Thai obese subjects, BMI ≥ 25 kg/m2 and age > 18 years, were recruited.

Exclusion criteria

Exclusion criteria: Subjects who were pregnant, lactating, menopause; had metabolic diseases (e.g. diabetes mellitus, hyper- or hypo-thyroidism, cushing syndrome), history of tea or caffeine hypersensitivity, a medical condition that causes weight gain known as secondary obesity (e.g. endocrine disorders, hypothalamic disorders, and some congenital conditions); used any forms of weight-reducing medications or any kinds of medications; and performed regular exercise (at least 30 min/session, 3 times per week48) were excluded.

Design outcomes

Primary

MeasureTime frame
body weight and BMI 0, 4, and 8 weeks of treatments Kg and kg/m2,waist and hip circumferences 0, 4, and 8 weeks of treatments cm

Secondary

MeasureTime frame
blood pressure 0, 4, and 8 weeks of treatments mmHg,Blood leptin, kisspeptin, and adiponectin levels 0, 4, and 8 weeks of treatments ng/ml,heart rate/heart rate variability (HRV) 0, 4, and 8 weeks of treatments beats/minute,fasting plasma insulin, triglyceride, total cholesterol, high-density lipoprotein (HDL) cholesterol, 0 and 8 weeks of treatments mg/dL,blood urea nitrogen (BUN), creatinine, and estimated glomerular filtration rate (eGFR) 0 and 8 weeks of treatments mg/dL,total bilirubin, direct bilirubin, aspartate aminotransferase, and alanine aminotransferase 0 and 8 weeks of treatments mg/dL

Countries

Thailand

Contacts

Public ContactChantacha Sitticharoon

Faculty of Medicine Siriraj Hospital

chantacha.sit@mahidol.ac.th+6624199721

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026